Headache Abortive Therapy in Patients with History of CVA
For patients with a history of cerebrovascular accident (CVA), non-steroidal anti-inflammatory drugs (NSAIDs) and triptans should be avoided due to increased risk of recurrent stroke, making acetaminophen (1000 mg) the safest first-line abortive therapy for headaches. 1, 2
Treatment Algorithm Based on Headache Type
For Tension-Type Headaches:
First-line: Acetaminophen 1000 mg
Second-line (if acetaminophen ineffective):
For Migraine Headaches:
First-line: Acetaminophen 1000 mg 1
- While less effective than migraine-specific medications, it offers the safest profile
Second-line options:
Avoid in CVA patients:
Special Considerations for CVA Patients
Medication Contraindications:
- Triptans: All triptans (sumatriptan, rizatriptan, etc.) are contraindicated due to their vasoconstrictive effects, which may increase stroke risk 1
- NSAIDs and Aspirin: May increase bleeding risk in patients with cerebrovascular disease 1
- Ergotamine derivatives: Contraindicated due to vasoconstrictive properties
Adjunctive Measures:
- Non-pharmacological approaches: rest in dark, quiet room
- Adequate hydration
- Stress management techniques
- Sleep hygiene optimization
Monitoring and Follow-up
- Monitor frequency of headaches and medication use
- Evaluate for medication overuse headache if using analgesics more than twice weekly 2
- Consider preventive therapy if headaches occur more than twice weekly 1
- Assess for new neurological symptoms that might indicate recurrent stroke rather than headache
Important Caveats
- Avoid opioids due to risk of dependency and medication overuse headache 1
- If headaches have atypical features or are accompanied by new neurological symptoms, consider neuroimaging to rule out recurrent CVA 1
- The combination of acetaminophen with caffeine may be more effective than acetaminophen alone but use caffeine with caution in patients with hypertension
By following this algorithm, clinicians can provide effective headache relief while minimizing the risk of recurrent cerebrovascular events in patients with a history of CVA.